Your search returned 8 results.

Results
	1.	Hybrid 2D/3D-quantitative structure-activity relationship and modeling studies perspectives of pepstatin A analogs as cathepsin D inhibitors. [electronic resource] by Arodola, Olayide A Soliman, Mahmoud Es Producer: 20171225 In: Future medicinal chemistry vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Quantum mechanics implementation in drug-design workflows: does it really help? [electronic resource] by Arodola, Olayide A Soliman, Mahmoud Es Producer: 20180612 In: Drug design, development and therapy vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Co-inhibition as a strategic therapeutic approach to overcome rifampin resistance in tuberculosis therapy: atomistic insights. [electronic resource] by Agoni, Clement Ramharack, Pritika Soliman, Mahmoud Es Producer: 20190520 In: Future medicinal chemistry vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Per-residue energy decomposition pharmacophore model to enhance virtual screening in drug discovery: a study for identification of reverse transcriptase inhibitors as potential anti-HIV agents. [electronic resource] by Cele, Favourite N Ramesh, Muthusamy Soliman, Mahmoud Es Producer: 20161230 In: Drug design, development and therapy vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Reversible versus irreversible inhibition modes of ERK2: a comparative analysis for ERK2 protein kinase in cancer therapy. [electronic resource] by Khan, Shama Bjij, Imane Betz, Robin M Soliman, Mahmoud Es Producer: 20190204 In: Future medicinal chemistry vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	'Piperazining' the catalytic gatekeepers: unraveling the pan-inhibition of SRC kinases; LYN, FYN and BLK by masitinib. [electronic resource] by Aljoundi, Aimen K Agoni, Clement Olotu, Fisayo A Soliman, Mahmoud Es Producer: 20200720 In: Future medicinal chemistry vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Tailored-pharmacophore model to enhance virtual screening and drug discovery: a case study on the identification of potential inhibitors against drug-resistant Mycobacterium tuberculosis (3R)-hydroxyacyl-ACP dehydratases. [electronic resource] by Machaba, Kgothatso E Mhlongo, Ndumiso N Dokurugu, Yussif M Soliman, Mahmoud Es Producer: 20170912 In: Future medicinal chemistry vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Novel quinazolinone-based 2,4-thiazolidinedione-3-acetic acid derivatives as potent aldose reductase inhibitors. [electronic resource] by Metwally, Kamel Pratsinis, Harris Kletsas, Dimitris Quattrini, Luca Coviello, Vito Motta, Concettina La El-Rashedy, Ahmed A Soliman, Mahmoud Es Producer: 20171225 In: Future medicinal chemistry vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)